Enfusion (ENFN) Competitors $10.63 +0.16 (+1.53%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENFN vs. AI, QLYS, VRNS, INTA, FRSH, ZETA, TENB, BOX, BRZE, and CLBTShould you be buying Enfusion stock or one of its competitors? The main competitors of Enfusion include C3.ai (AI), Qualys (QLYS), Varonis Systems (VRNS), Intapp (INTA), Freshworks (FRSH), Zeta Global (ZETA), Tenable (TENB), BOX (BOX), Braze (BRZE), and Cellebrite DI (CLBT). These companies are all part of the "prepackaged software" industry. Enfusion vs. C3.ai Qualys Varonis Systems Intapp Freshworks Zeta Global Tenable BOX Braze Cellebrite DI C3.ai (NYSE:AI) and Enfusion (NYSE:ENFN) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings. Is AI or ENFN more profitable? Enfusion has a net margin of 1.70% compared to C3.ai's net margin of -79.17%. Enfusion's return on equity of 6.67% beat C3.ai's return on equity.Company Net Margins Return on Equity Return on Assets C3.ai-79.17% -31.31% -26.09% Enfusion 1.70%6.67%4.86% Do analysts recommend AI or ENFN? C3.ai presently has a consensus target price of $35.00, suggesting a potential downside of 3.69%. Enfusion has a consensus target price of $10.00, suggesting a potential downside of 5.93%. Given C3.ai's stronger consensus rating and higher possible upside, equities research analysts clearly believe C3.ai is more favorable than Enfusion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score C3.ai 4 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.14Enfusion 3 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.80 Does the MarketBeat Community believe in AI or ENFN? C3.ai received 364 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 50.68% of users gave C3.ai an outperform vote while only 20.41% of users gave Enfusion an outperform vote. CompanyUnderperformOutperformC3.aiOutperform Votes37450.68% Underperform Votes36449.32% EnfusionOutperform Votes1020.41% Underperform Votes3979.59% Which has more volatility & risk, AI or ENFN? C3.ai has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Which has preferable earnings and valuation, AI or ENFN? Enfusion has lower revenue, but higher earnings than C3.ai. C3.ai is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioC3.ai$346.54M13.32-$279.70M-$2.21-16.44Enfusion$195.16M7.00$6.03M$0.04265.75 Does the media favor AI or ENFN? In the previous week, C3.ai had 32 more articles in the media than Enfusion. MarketBeat recorded 39 mentions for C3.ai and 7 mentions for Enfusion. Enfusion's average media sentiment score of 0.92 beat C3.ai's score of 0.21 indicating that Enfusion is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment C3.ai 12 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Enfusion 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of AI or ENFN? 39.0% of C3.ai shares are owned by institutional investors. Comparatively, 81.1% of Enfusion shares are owned by institutional investors. 33.5% of C3.ai shares are owned by insiders. Comparatively, 36.4% of Enfusion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryC3.ai beats Enfusion on 10 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENFN vs. The Competition Export to ExcelMetricEnfusionPrepackaged software IndustryComputer SectorNYSE ExchangeMarket Cap$1.37B$25.30B$24.25B$19.19BDividend YieldN/A2.25%2.71%3.57%P/E Ratio265.8296.89270.7441.22Price / Sales7.0013.943,157.2017.59Price / Cash73.8991.5833.6621.28Price / Book17.4312.857.755.32Net Income$6.03M$446.45M$661.21M$989.67M7 Day Performance-0.19%2.04%0.71%-3.45%1 Month Performance6.20%10.73%6.74%-3.74%1 Year Performance9.93%26.36%22.24%12.06% Enfusion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENFNEnfusion2.8285 of 5 stars$10.63+1.5%$10.00-5.9%+10.2%$1.37B$195.16M265.821,102Analyst ForecastNews CoverageHigh Trading VolumeAIC3.ai2.9816 of 5 stars$42.45+7.6%$35.55-16.3%+22.2%$5.39B$346.54M-17.86700Analyst UpgradeInsider TradeAnalyst RevisionQLYSQualys1.3654 of 5 stars$146.98-0.4%$152.80+4.0%-30.3%$5.38B$554.46M32.502,188VRNSVaronis Systems4.5304 of 5 stars$47.62+1.1%$59.80+25.6%+1.5%$5.36B$499.16M-63.562,233Analyst ForecastINTAIntapp2.1969 of 5 stars$68.79+0.2%$59.27-13.8%+72.1%$5.32B$447.75M-238.171,235Analyst ForecastInsider TradeGap DownFRSHFreshworks2.8227 of 5 stars$16.94+2.4%$18.69+10.3%-34.9%$5.13B$685.96M-48.684,900Analyst ForecastInsider TradeNews CoverageGap DownZETAZeta Global3.9509 of 5 stars$21.54-3.5%$37.86+75.8%+124.8%$5.11B$728.72M-31.891,783Analyst ForecastTENBTenable4.1737 of 5 stars$42.55+2.3%$50.63+19.0%-8.9%$5.11B$798.71M-81.571,999Analyst ForecastNews CoveragePositive NewsBOXBOX4.7454 of 5 stars$32.49flat$34.75+7.0%+23.5%$4.67B$1.07B40.612,530Analyst ForecastInsider TradeAnalyst RevisionBRZEBraze3.6483 of 5 stars$44.63+7.2%$53.74+20.4%-14.7%$4.58B$563.97M-36.521,548Analyst ForecastInsider TradeCLBTCellebrite DI0.9922 of 5 stars$20.27+2.0%$20.57+1.5%+175.0%$4.17B$325.11M-12.831,008 Related Companies and Tools Related Companies AI Alternatives QLYS Alternatives VRNS Alternatives INTA Alternatives FRSH Alternatives ZETA Alternatives TENB Alternatives BOX Alternatives BRZE Alternatives CLBT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ENFN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENFN Stock Alerts